易明医药：2025年半年度公司实现营业收入311445583.30元

Core Insights - The company reported a revenue of 311,445,583.30 yuan for the first half of 2025, representing a year-on-year decline of 11.52% [2] - The net profit attributable to shareholders of the listed company was 37,557,144.18 yuan, showing a year-on-year decrease of 5.27% [2] Financial Performance - Revenue for the first half of 2025: 311.45 million yuan, down 11.52% year-on-year [2] - Net profit for the same period: 37.56 million yuan, down 5.27% year-on-year [2]